Split History
ETFs Holding GALE »    GALE Historical Stock Prices »
Video: What is a Stock Split?


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
SELLAS Life Sciences Group is a biopharmaceutical company developing hematology and oncology therapeutics. Co.'s pipeline consists of multiple mid- to late-stage clinical assets, including its hematology asset, GALE-401, and its cancer immunotherapy programs including NeuVax™ (nelipepimut-S), GALE-301 and GALE-302. GALE-401 is a controlled release version of the approved drug anagrelide for the treatment of elevated platelets in patients with myeloproliferative neoplasms. NeuVax is in clinical trials in breast cancer. GALE-301 and GALE-302 have completed early stage trials in ovarian, endometrial and breast cancers. According to our GALE split history records, GALE has had 1 split.
GALE split history picture
GALE (GALE) has 1 split in our GALE split history database. The split for GALE took place on November 14, 2016. This was a 1 for 20 reverse split, meaning for each 20 shares of GALE owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 50 share position following the split.

When a company such as GALE conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.

Looking at the GALE split history from start to finish, an original position size of 1000 shares would have turned into 50 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into GALE shares, starting with a $10,000 purchase of GALE, presented on a split-history-adjusted basis factoring in the complete GALE split history. GALE split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 05/24/2010
End date: 12/29/2017
Start price/share: $74.00
End price/share: $0.26
Dividends collected/share: $0.00
Total return: -99.65%
Average Annual Total Return: -52.43%
Starting investment: $10,000.00
Ending investment: $35.15
Years: 7.61
Date Ratio
11/14/20161 for 20
GALE is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

GALT Split History
GBSN Split History
GENE Split History
GERN Split History
GILD Split History
GNCA Split History
GNVC Split History
GRFS Split History
GTS Split History
GTXI Split History

Laredo Petroleum, Inc. (LPI)
Global Eagle Entertainment Inc. (ENT)
ToughBuilt Industries, Inc. (TBLT)
Cyclacel Pharmaceuticals, Inc. (CYCC)
Chesapeake Energy Corporation (CHK)
Direxion Daily Gold Miners Index Bull 3X Shares (NUGT)
Direxion Zacks MLP High Income Index Shares (ZMLP)
Direxion Daily Retail Bull 3X Shares (RETL)
Direxion Daily Robotics, Artificial Intelligence & Automation Index Bull 3X Shares (UBOT)
Direxion Daily Junior Gold Miners Index Bull 3X Shares (JNUG)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

GALE Insider Buying

GALE Split History | www.SplitHistory.com | Copyright © 2013 - 2020, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.